All sponsors

SUNHO(China)BioPharmaceutical CO., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS8
PHASE 3 / 2-32
RECRUITING5
READOUTS ≤12 MONTHS0
READOUT SLIPPED >6 MO33%

Delay Index: of 6 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open SUNHO(China)BioPharmaceutical CO., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
IAP0971
NCT06255964
P1/2Not yet recruitingBladder Cancer2362024-10-07
IBB0979
NCT05991583
P1/2RecruitingAdvanced Malignant Tumors252025-11-30 (+17 mo)
IAP0971
NCT06223841
P1/2RecruitingAdvanced Malignant Tumors502026-03-01
IAE0972+ Methotrexate
NCT06719479
P2/3Not yet recruitingNPC; HNSCC602028-01-01
IAH0968
NCT06504732
P2/3RecruitingStomach Neoplasms; Solid Tumor5742028-07 (+24 mo)
IBB0979
NCT07076095
P2Not yet recruitingSmall Cell Lung Cancer2002028-08-01
IAP0971
NCT06581419
P1/2RecruitingAdvanced Malignant Neoplasm; Advanced or Metastatic Non-small Cell Lung Cancer782029-08-01
IBD0333
NCT06292208
P1/2RecruitingMTD482029-12-31